Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00083954
Status:
COMPLETED
Last Update Posted:
2013-01-04
First Post:
2004-06-03
Brief Title:
Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Bipolar Disorder |
Keywords:
| Name | View |
|---|---|
| Bipolar I Disorder | View |